Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103

This study aimed to investigate whether pre-chemotherapy anti-mullerian hormone (AMH) is a biomarker for chemotherapy-related amenorrhea (CRA) in breast cancer patients. A multicenter randomized controlled trial, ECOG5103, assigned patients with early stage breast cancer to standard doxorubicin-cycl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Ruddy, Kathryn J., O'Neill, Anne, Miller, Kathy D., Schneider, Bryan P., Baker, Emily, Sparano, Joseph A., Dang, Chau, Northfelt, Donald W., Sledge, George W., Partridge, Ann H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334112/
https://ncbi.nlm.nih.gov/pubmed/24584876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2891-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky